Anti-HIV-1 activity of the Iboga alkaloid congener 18-methoxycoronaridine

Planta Medica

Volumn 70, Issue 9, 2004, Pages 808-812

  Silva, Edinete M ^a   Cirne Santos, Claudio C ^a,b   Frugulhetti, Izabel C P P ^b   Galvão Castro, Bernardo ^a,c   Saraiva, Elvira M B ^d   Kuehnes, Martin E ^e   Bou Habib, Dumith Chequer ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^c ESCOLA BAHIANA DE MEDICINA E SAÚDE PÚBLICA   (Brazil)

^d FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^e UNIVERSITY OF VERMONT   (United States)

Author keywords

18 methoxycoronaridine; AIDS; HIV 1; Iboga alkaloid; Reverse transcriptase

Indexed keywords

18 METHOXYCORONARIDINE; ALKALOID; CHEMOKINE RECEPTOR; IBOGAINE; RNA DIRECTED DNA POLYMERASE;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFECT; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IC 50; IN VITRO STUDY; MACROPHAGE; PERIPHERAL BLOOD MONONUCLEAR CELL; THERAPEUTIC INDEX; VIRUS INFECTION; VIRUS INHIBITION; VIRUS ISOLATION; VIRUS REPLICATION;

ANTI-HIV AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; HIV-1; HUMANS; IBOGAINE; LEUKOCYTES, MONONUCLEAR; PHYTOTHERAPY; PLANT EXTRACTS; TABERNAEMONTANA;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 5444221866     PISSN: 00320943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-827227     Document Type: Article

References (22)

1. WHO /UNAIDS. Global summary of the HIV/AIDS HIVIAIDS epidemic. December 2003 www.unaids.org,
2. Berger EA, Murphy PM, Farber JM. Chemokine receptors as HIV-1 co-receptors: roles in viral entry, tropism, and disease. Ann Rev Immunol 1999; 17: 657-700
3. Pantaleo G, Graziosi C, Demarest JF, Butini L, Montroni M, Fox CH, Orestein JM, Kotler DP, Fauci A. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 1993; 362: 355-8
4. Pallela Jr FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DI, Holmberg SD. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. New Engl J Med 1998; 338: 853-60
5. Blankson JN, Persaud D, Siliciano R. The challenge of viral reservoir in HIV-1 infection. Annu Rev Med 2002; 53: 557-93
6. Richman DD. HIV chemotherapy. Nature 2001; 410: 995-1001
7. Condra JH, Miller MD, Hazuda DJ, Emini EA. Potential new therapies for the treatment of HIV-1 infection. Annu Rev Med 2002; 53: 541-55
8. Maisonneuve IM, Glick SD. Anti-addictive actions of an iboga alkaloid congener: a novel mechanism for a novel treatment. Pharmacol Biochem Behav 2003; 75: 607-18
9. Glick SD, Maisonneuve IM, Szumlinski KK. 18-Methoxycoronaridine (18-MC) and ibogaine. Comparison of antiaddictive efficacy, toxicity and mechanisms of action. Ann N Y Acad Sci 2000; 914: 369-86
10. Delorenzi JC, Attias M, Gattass CR, Andrade M, Rezende C, Pinto AC, Henriques AT, Bou-Habib DC, Saraiva EMB. Antileishmanial activity of an indole alkaloid from Peschiera australis. Antimicrob Agents Chemother 2001; 45: 1349-54
11. Delorenzi JC, Freire-de-Lima L, Gattass CR, Costa D, He AL, Kuehne ME, Saraiva EMB. In vitro activities of iboga alkaloid congeners coronaridine and 18-methoxycoronaridine against Leishmania amazonensis. Antimicrob Agents Chemother 2002; 46: 2111-5
12. Vlietinck AJ, De Bruyne T, Apers S, Pieters LA. Plant-derived leading compounds for chemotherapy of human immunodeficiency virus (HIV) infection. Planta Medica 1998; 64: 97-109
13. Brazilian Network for HIV Isolation and Characterization. HIV-1 diversity in Brazil: genetic, biologic, and immunologic characterization of HIV-1 strains in three potential HIV vaccine evaluation sites. J Acquir Immune Defic Syndr 2000; 23: 184-93
14. Ferraro GA, Mello MAG, Sutmoller F, Van Weyenberg J, Brazilian Network for HIV Isolation and Characterization, Shindo N, Galvão-Castro B, Bou-Habib DC. Biological characterization and chemokine receptor usage of HIV type 1 isolates prevalent in Brazil. AIDS Res Hum Retroviruses 2001; 17: 1241-7
15. Bandarage UK, Kuehne ME, Glick SD. Total synthesis of racemic albifloranine and its anti-addictive congeners, including 18- methoxycoronaridine, Tetrahedron 1999; 55: 9405-24
16. Da Matta AD, Santos CVE, Pereira HS, Frugulhetti ICPP, Oliveira MRP, Souza MCBV, Moussatché N, Ferreira VE Synthesis of novel nucleosides of 4-oxoquinoline-3-carboxylic acid analogues. Heteroatom Chemistry 1999; 10: 197-202
17. McMahon JB, Currens MJ, Gulakowski RJ, Bucheit RW, Lackman-Smith C, Hallock YF, Boyd MR. Michellamine B, a novel plant alkaloid, inhibits human immunodeficiency virus-induced cell killing by at least two distinct mechanisms. Antimicrob Agents Chemother 1995; 39: 484-8
18. Tan GT, Kinghorn A D, Hughes SH, Pezzuto JM. Psychotrine and its O-methyl ether are selective inhibitors of human immunodeficiency virus-1 reverse transcriptase. J Biol Chem 1991; 266: 23 529-36
19. Walker BD, Kowalski M, Goh WC, Kozarsky K, Krieger M, Rosen C, Rohrschneider L, Haseltine WA, Sodroski J. Inhibition of human immunodeficiency virus syncytium formation and virus replication by castanospermine. Proc Natl Acad Sci USA 1987; 84: 8120-4
20. Chao CC, Gekker G, Sheng WS, Hu S, Peterson PK. U50488 inhibits HIV-1 expression in acutely infected monocyte-derived macrophages. Drug Alcohol Depend 2001; 62: 149-54
21. Peterson PK, Gekker G, Lokensgard JR, Bidlack JM, Chang AC, Fang X, Portoghese PS. Kappa-opioid receptor agonist suppression of HIV-1 expression in CD4+ lymphocytes. Biochem Pharmacol 2001; 61: 1145-51
22. Chapuis AG, Rizzardi GP, D'Agostino C, Attinger A, Knabenhans C, Fleury S, Acha-Orbea H, Pantaleo G. Effects of mycophenolic acid on human immunodeficiency virus infection in vitro and in vivo. Nat Med 2000; 6: 762-8